Literature DB >> 15037707

Rasmussen encephalitis with active inflammation and delayed seizures onset.

I Korn-Lubetzki1, C G Bien, J Bauer, M Gomori, H Wiendl, L Trajo, H Ovadia, B Wilken, V H Hans, C E Elger, H Hurvitz, I Steiner.   

Abstract

Severe focal epilepsy is regarded as a clinical hallmark of Rasmussen encephalitis (RE). The authors report two children with progressive hemiparesis, contralateral hemispheric atrophy, and pathologic features characteristic for RE. At histologic diagnosis and over several months, neither patient experienced seizures. The report enlarges the clinical spectrum of RE and suggests that seizures are not an obligatory presenting symptom of the disorder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037707     DOI: 10.1212/01.wnl.0000115393.67403.53

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Rasmussen's encephalitis, should absence of seizures influence or delay treatment?

Authors:  K M Gorman; M Farrell; C Madigan; M D King; A Shahwan
Journal:  Childs Nerv Syst       Date:  2015-09-26       Impact factor: 1.475

2.  Epilepsy surgery in adult-onset Rasmussen's encephalitis: case series and review of the literature.

Authors:  Sara Casciato; Carlo Di Bonaventura; Anna Teresa Giallonardo; Jinane Fattouch; Pier Paolo Quarato; Addolorata Mascia; Alfredo D'Aniello; Andrea Romigi; Vincenzo Esposito; Giancarlo Di Gennaro
Journal:  Neurosurg Rev       Date:  2015-04-16       Impact factor: 3.042

Review 3.  Rasmussen encephalitis with dual pathology in a patient without seizures: case report and literature review.

Authors:  Vijay M Ravindra; Marcus D Mazur; Carrie A Mohila; Matthew T Sweney; Aimee Hersh; Robert J Bollo
Journal:  Childs Nerv Syst       Date:  2015-06-02       Impact factor: 1.475

Review 4.  [Recent insights into Rasmussen encephalitis].

Authors:  C G Bien; C E Elger
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

Review 5.  Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

Authors:  Sophia Varadkar; Christian G Bien; Carol A Kruse; Frances E Jensen; Jan Bauer; Carlos A Pardo; Angela Vincent; Gary W Mathern; J Helen Cross
Journal:  Lancet Neurol       Date:  2014-02       Impact factor: 44.182

Review 6.  Encephalitis and epilepsy.

Authors:  Jan Bauer; Christian G Bien
Journal:  Semin Immunopathol       Date:  2009-09-11       Impact factor: 9.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.